Trade Mark Journal No.2026/028 10 July 2026

WO0000001924407 (44)

Office of origin: United States of America

Date of International Registration:14 April 2026
Date of designation in the UK: 14 April 2026
Image for mark 1924407 RISKREVEAL

Class 44
Medical testing for diagnostic or treatment purposes; medical diagnostic testing for analysis of tumor tissue in the field of oncology; medical molecular diagnostic testing for analysis of tumor tissue in the field of oncology; medical prognostic testing for analysis of tumor tissue in the field of oncology; medical molecular prognostic testing for analysis of tumor tissue in the field of oncology; medical diagnostic molecular treatment stratification testing for analysis of tumor tissue in the field of oncology; medical prognostic molecular treatment stratification testing for analysis of tumor tissue in the field of oncology; medical testing of tumor tissue for use in risk segregation and managing disease treatment, namely, cancer.

RAZOR GENOMICS, INC.

Representative: DAVID R. STEVENS STEVENS LAW GROUP, 1754 TECHNOLOGY DR STE 226, SAN JOSE CA 95110, UNITED STATES OF AMERICA